FierceBiotech

With updated FDA nod, BD aims to revive beleaguered Alaris infusion pumps

Since the start of 2020, BD’s Alaris infusion pumps have been the subject of more than half-a-dozen Class I hardware and software recalls, a handful of cybersecurity warnings and a years-long ...
Nasdaq

BD (BDX) Receives FDA Nod to Address Critical Infusion Needs

Becton, Dickinson and Company BDX, popularly known as BD, recently received the FDA’s 510(k) clearance for its updated BD Alaris Infusion System. This is expected to enable both remediation and a ...
Seeking Alpha

BD Receives FDA 510(k) Clearance for Updated BD Alaris™ Infusion System

This clearance covers updated hardware features for Point-of-Care Unit (PCU), large volume pumps, syringe pumps, patient-controlled analgesia (PCA) pumps, respiratory monitoring and ...
Healio

FDA clears updated Alaris infusion pump; recall remediation remains ‘top priority’

Please provide your email address to receive an email when new articles are posted on . The FDA granted 510(k) clearance to Becton Dickinson’s updated Alaris infusion pump, allowing the company to ...
WDAF-TV

BD Receives FDA 510(k) Clearance for Updated BD Alaris™ Infusion System

FRANKLIN LAKES, N.J., July 21, 2023 /PRNewswire/ -- BD (Becton, Dickinson and Company) (NYSE: BDX), a leading global medical technology company, today announced that the updated BD Alaris™ Infusion ...